Isoforms of Neuropilin-2 Denote Unique Tumor-Associated Macrophages in Breast Cancer

Tumor-associated macrophages (TAMs) exert profound influence over breast cancer progression, promoting immunosuppression, angiogenesis, and metastasis. Neuropilin-2 (NRP2), consisting of the NRP2a and NRP2b isoforms, is a co-receptor for heparin-binding growth factors including VEGF-C and Class 3 Semaphorins. Selective upregulation in response to environmental stimuli and independent signaling pathways endow the NRP2 isoforms with unique functionality, with NRP2b promoting increased Akt signaling via receptor tyrosine kinases including VEGFRs, MET, and PDGFR. Although NRP2 has been shown to regulate macrophage/TAM biology, the role of the individual NRP2a/NRP2b isoforms in TAMs has yet to be evaluated. Using transcriptional profiling and spectral flow cytometry, we show that NRP2 isoform expression was significantly higher in TAMs from murine mammary tumors. NRP2a/NRP2b levels in human breast cancer metastasis were dependent upon the anatomic location of the tumor and significantly correlated with TAM infiltration in both primary and metastatic breast cancers. We define distinct phenotypes of NRP2 isoform-expressing TAMs in mouse models of breast cancer and within malignant pleural effusions from breast cancer patients which were exclusive of neuropilin-1 expression. Genetic depletion of either NRP2 isoform in macrophages resulted in a dramatic reduction of LPS-induced IL-10 production, defects in phagosomal processing of apoptotic breast cancer cells, and increase in cancer cell migration following co-culture. By contrast, depletion of NRP2b, but not NRP2a, inhibited production of IL-6. These results suggest that NRP2 isoforms regulate both shared and unique functionality in macrophages and are associated with distinct TAM subsets in breast cancer.

[1]  J. Luketich,et al.  Experimental respiratory exposure to putative Gulf War toxins promotes persistent alveolar macrophage recruitment and pulmonary inflammation. , 2021, Life sciences.

[2]  P. Erben,et al.  Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer , 2021, Genes.

[3]  Jian-Min Yuan,et al.  HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions , 2020, Frontiers in Immunology.

[4]  J. Luketich,et al.  Characteristics of Malignant Pleural Effusion Resident CD8+ T Cells from a Heterogeneous Collection of Tumors , 2020, International journal of molecular sciences.

[5]  M. Courreges,et al.  Modulation of LPS-induced inflammatory cytokine production by a novel glycogen synthase kinase-3 inhibitor , 2020, European Journal of Pharmacology.

[6]  Y. Peterson,et al.  Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. , 2020, The Journal of thoracic and cardiovascular surgery.

[7]  M. Wirth,et al.  Neuropilin‐2 is an independent prognostic factor for shorter cancer‐specific survival in patients with acinar adenocarcinoma of the prostate , 2020, International journal of cancer.

[8]  George C. Tseng,et al.  Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors , 2019, Journal of Immunotherapy for Cancer.

[9]  A. Y. Mitrophanov,et al.  LPS‐stimulated NF‐κB p65 dynamic response marks the initiation of TNF expression and transition to IL‐10 expression in RAW 264.7 macrophages , 2018, Physiological reports.

[10]  A. Mildner,et al.  Developmental and Functional Heterogeneity of Monocytes. , 2018, Immunity.

[11]  S. Ethier,et al.  ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen. , 2018, Vaccine.

[12]  Jasjit K. Banwait,et al.  Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions. , 2018, Cancer research.

[13]  M. Hernandez,et al.  Neuropilin-2 regulates airway inflammatory responses to inhaled lipopolysaccharide. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[14]  M. Apicella,et al.  Downregulating Neuropilin-2 Triggers a Novel Mechanism Enabling EGFR-Dependent Resistance to Oncogene-Targeted Therapies. , 2018, Cancer research.

[15]  S. Batra,et al.  Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy , 2017, Front. Immunol..

[16]  S. Schellenburg,et al.  Role of neuropilin-2 in the immune system. , 2017, Molecular immunology.

[17]  Rohit Bhargava,et al.  Exome-capture RNA-sequencing of decade-old breast cancers and matched decalcified bone metastases identifies clinically actionable targets , 2017, bioRxiv.

[18]  Adrian V. Lee,et al.  Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases , 2017, JAMA oncology.

[19]  L. Landi,et al.  The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer , 2017, Science Signaling.

[20]  Hao Chen,et al.  Cytofkit: A Bioconductor Package for an Integrated Mass Cytometry Data Analysis Pipeline , 2016, PLoS Comput. Biol..

[21]  H. Neumann,et al.  Polysialylation and lipopolysaccharide‐induced shedding of E‐selectin ligand‐1 and neuropilin‐2 by microglia and THP‐1 macrophages , 2016, Glia.

[22]  M. Yamakawa,et al.  Specific Neuropilins Expression in Alveolar Macrophages among Tissue-Specific Macrophages , 2016, PloS one.

[23]  E. Yeh,et al.  Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy , 2016, npj Breast Cancer.

[24]  Miao Sun,et al.  Prognostic significance of VEGF‐C, semaphorin 3F, and neuropilin‐2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis , 2015, Journal of surgical oncology.

[25]  B. Fuchs,et al.  Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma. , 2015, American journal of translational research.

[26]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[27]  Wilbur H. Chen,et al.  Changes in polysialic acid expression on myeloid cells during differentiation and recruitment to sites of inflammation: role in phagocytosis. , 2014, Glycobiology.

[28]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[29]  L. Claesson‐Welsh,et al.  NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation. , 2014, Developmental cell.

[30]  M. Mazzone,et al.  Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. , 2013, Cancer cell.

[31]  C. Korch,et al.  Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition. , 2013, Cancer research.

[32]  D. Finkelstein,et al.  Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis , 2013, Nature.

[33]  Ashok Kumar,et al.  SHP-1–Pyk2–Src Protein Complex and p38 MAPK Pathways Independently Regulate IL-10 Production in Lipopolysaccharide-Stimulated Macrophages , 2013, The Journal of Immunology.

[34]  Luke H. Hoeppner,et al.  Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial α5 integrin. , 2013, Cancer research.

[35]  N. Zhang,et al.  S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β. , 2012, Experimental cell research.

[36]  V. Calléja,et al.  A direct role for Met endocytosis in tumorigenesis , 2011, Nature Cell Biology.

[37]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[38]  Ashok Kumar,et al.  IL-6 Production Is Positively Regulated by Two Distinct Src Homology Domain 2-Containing Tyrosine Phosphatase-1 (SHP-1)–Dependent CCAAT/Enhancer-Binding Protein β and NF-κB Pathways and an SHP-1–Independent NF-κB Pathway in Lipopolysaccharide-Stimulated Bone Marrow-Derived Macrophages , 2011, The Journal of Immunology.

[39]  L. Naldini,et al.  Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. , 2011, Cancer cell.

[40]  G. Cheng,et al.  Lipopolysaccharide-Mediated IL-10 Transcriptional Regulation Requires Sequential Induction of Type I IFNs and IL-27 in Macrophages , 2010, The Journal of Immunology.

[41]  B. Binder,et al.  Anti‐inflammatory properties of the PI3K pathway are mediated by IL‐10/DUSP regulation , 2010, Journal of leukocyte biology.

[42]  J. Rodríguez-Fernández,et al.  Polysialylated neuropilin-2 enhances human dendritic cell migration through the basic C-terminal region of CCL21. , 2010, Glycobiology.

[43]  P. De Baetselier,et al.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.

[44]  Jie J. Zheng,et al.  ReviewPDZ domains and their binding partners : structure , specificity , and modification , 2010 .

[45]  A. Sica,et al.  A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. , 2009, Blood.

[46]  T. Sanke,et al.  Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression , 2009, BMC Cancer.

[47]  L. Ivashkiv,et al.  Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. , 2009, Human immunology.

[48]  William King,et al.  High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. , 2009, The American journal of pathology.

[49]  A. Mercurio,et al.  Metabolic Stress Induces the Lysosomal Degradation of Neuropilin-1 but Not Neuropilin-2* , 2008, Journal of Biological Chemistry.

[50]  Craig Murdoch,et al.  The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.

[51]  Michael C. Ostrowski,et al.  Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. , 2006, Molecular immunology.

[52]  Anne E Carpenter,et al.  A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.

[53]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[54]  Fumio Nakamura,et al.  Structural and functional relation of neuropilins. , 2002, Advances in experimental medicine and biology.

[55]  Francisco Diaz-Mitoma,et al.  The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages* , 2001, The Journal of Biological Chemistry.

[56]  M. Klagsbrun,et al.  Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. , 2000, Genomics.

[57]  S. Smale,et al.  A Prominent Role for Sp1 During Lipopolysaccharide- Mediated Induction of the IL-10 Promoter in Macrophages1 , 2000, The Journal of Immunology.

[58]  H. Cai,et al.  Cloning and Characterization of Neuropilin-1-Interacting Protein: A PSD-95/Dlg/ZO-1 Domain-Containing Protein That Interacts with the Cytoplasmic Domain of Neuropilin-1 , 1999, The Journal of Neuroscience.

[59]  Shay Soker,et al.  Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.

[60]  C. Goodman,et al.  The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules , 1993, Cell.